Table 2. Quality assessment of the included studies.
Reasons for | Incomplete data | Efforts to address | ||||
Consecutive | exclusion | adequately | potential sources | % loss to | ||
First author and year | patients? | reported? | addressed? | of bias? | Follow-up time | follow-up |
Research committee of | ||||||
British Thoracic | Yes | Yes | Yes | Yes | 12 months | 8% |
Society, 1992 | ||||||
Agnelli, 2001 | Yes | Yes | Yes | Yes | at least 2 years | 0% |
Agnelli, 2003 | Yes | Yes | Yes | Yes | at least 1 year | 0% |
Agnelli, 2007 | Yes | Yes | Yes | Yes | at least 4 | 0% |
months | ||||||
Aujeskey, 2011 | Yes | Yes | Yes | Yes | 3 months | 0.2% |
Van Bladel, 2010 | Yes | Yes | Yes | Yes | 3 months | 1.2% |
Bona, 2000 | Yes | No | Unclear | Unclear | Unclear | Unclear |
Büller, 2003 | Yes | Yes | Yes | Yes | 3 months | 0.5% |
Büller, 2008 | Unclear | No | Yes | Yes | 3 months | 0.7% |
Caprini, 1999 | Yes | Yes | No | No | 6 months | Unclear |
Cassiopea, 2012 | Yes | Yes | Yes | Yes | 6–12 months | Unclear |
Columbus Investigators, 1997 | Yes | Yes | Yes | Yes | 3 months | 0% |
Das, 1996 | Yes | Yes | Yes | Yes | 3 months | Unclear |
Daskapoulos, 2005 | Yes | Yes | Yes | Yes | 12 months | 0% |
Einstein Investigators, 2010 | Yes | Yes | Yes | Yes | 3–12 months | 1% |
Einstein Investigators, 2012 | Yes | Yes | Yes | Unclear | Unclear | 0.4% |
Fiesinger, 2005 | Unclear | Yes | Yes | Yes | 6 ½ months | 1.1% |
Galilei Investigators, 2004 | Yes | Yes | Yes | Yes | 3 months | 0% |
Van Gogh Investigators, 2007 | Yes | Yes | Yes | Yes | 3 months | 0.8% |
Gonzalez-Fajardo, 1999 | Yes | Yes | Yes | Yes | 12 months | 1.6% |
Heidinger, 2000 | No | Yes | No | Unclear | Unclear | Unclear |
Kearon, 1999 | Yes | Yes | Yes | Yes | Average 10 | Unclear |
months | ||||||
Kearon, 2003 | Yes | Yes | Yes | Yes | Average 2.4 | 0.1% |
years | ||||||
Kearon, 2004 | Yes | Yes | Yes | Yes | 12 months | 0% |
Kearon, 2006 | Yes | Yes | Yes | Yes | 3 months | 0% |
Koopman, 1996 | Yes | Yes | Yes | Yes | 6 months | 1% |
Levine, 1995 | Unclear | Yes | No | Yes | 12 months | 3.4% |
López-Beret, 2001 | Yes | Yes | Unclear | Unclear | 12 months | Unclear |
Meyer, 2002 | Yes | Yes | Unclear | Unclear | 6 months | Unclear |
Monreal, 1998 | Yes | Yes | Unclear | No | 3–6 months | Unclear |
Nielsen, 1993 | Yes | No | Unclear | Yes | 3 months | Unclear |
Palareti, 2000 | Yes | Yes | Yes | Yes | Average 10–11 | Unclear |
months | ||||||
Pérez-de-Llano, 2010 | Yes | Yes | Yes | Yes | 6 months | 6% |
Pini, 1994 | Yes | Yes | Yes | Yes | 9 months | 0% |
Poller, 2008 | Unclear | Yes | Unclear | Yes | Average 17 | Unclear |
months | ||||||
Poli, 2007 | Yes | Yes | Yes | Yes | At least 1 year | 8.1% |
or until | ||||||
recurrence | ||||||
Prandoni, 2004 | Yes | Yes | Yes | Yes | 5 years | 1.7% |
Santamaria, 2006 | Unclear | Yes | No | No | Median | Unclear |
98 days | ||||||
Schulman, 1994 | Unclear | Yes | Yes | Yes | At least 6 | Unclear |
months | ||||||
Schulman, 2009 | Unclear | Yes | Yes | Yes | 6 months | 0.5% |